RESUMEN
An enzyme-immobilized platform for biocatalysis was developed through 3D printing of a hydrogel ink comprising dimethacrylate-functionalized Pluronic F127 (F127-DMA) and sodium alginate (Alg) with laccase that can be done at ambient temperature, followed by UV-induced cross-linking. Laccase is an enzyme that can degrade azo dyes and various toxic organic pollutants. The fiber diameter, pore distance, and surface-to-volume ratio of the laccase-immobilized and 3D-printed hydrogel constructs were varied to determine their effects on the catalytic activity of the immobilized enzyme. Among the three geometrical designs investigated, the 3D-printed hydrogel constructs with flower-like geometry exhibited better catalytic performance than those with cubic and cylindrical geometries. Once tested against Orange II degradation in a flow-based format, they can be reused for up to four cycles. This research demonstrates that the developed hydrogel ink can be used to fabricate other enzyme-based catalytic platforms that can potentially increase their industrial usage in the future.
Asunto(s)
Hidrogeles , Tinta , Biocatálisis , Lacasa , Catálisis , Impresión TridimensionalRESUMEN
Recently, pH-responsive polymeric micelles have gained significant attention as effective carriers for anti-cancer drug delivery. Herein, pH-responsive polymeric micelles were constructed by a simple post-polymerization modification of a single homopolymer, poly(pentafluorophenyl acrylate) (PPFPA). The PPFPA was first subjected to modification with 1-amino-2-propanol yielding the amphiphilic copolymer of poly(pentafluorophenyl acrylate)-ran-poly(N-(2-hydroxypropyl acrylamide)). A series of amphiphilic random copolymers of different compositions could self-assemble into spherical micelles with a unimodal size distribution in aqueous solution. Then, 1-(3-aminopropyl)imidazole (API), a reagent to introduce charge conversional entities, was reacted with the remaining PPFPA segment in the micellar core resulting in API-modified micelles which can encapsulate doxorubicin (DOX), a hydrophobic anti-cancer drug. As monitored by dynamic light scattering, the API-modified micelles underwent disintegration upon pH switching from 7.4 to 5.0, presumably due to imidazolyl group protonation. This pH-responsiveness of the API-modified micelles was responsible for the faster and greater in vitro DOX release in an acidic environment than neutral pH. Cellular uptake studies revealed that the developed carriers were internalized into MDA-MB-231 cells within 30 min via endocytosis and exhibited cytotoxicity in a dose-dependent manner.